Apatinib Plus Vinorelbine vs Vinorelbine Alone for Patients With Metastatic TNBC Who Failed First-/Second-Line Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial
NPJ Breast Cancer 2022 Sep 20;8(1)110, DD Li, ZH Tao, BY Wang, LP Wang, J Cao, XC Hu, J ZhangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.